DOCSLIB.ORG

Major Histocompatibility Complex, MHC

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Major Histocompatibility Complex, MHC Wei Haiming [email protected] 1 Blood group antigen and blood transfusion reaction University of Vienna Professor A. Weichselbaum: Discovered the bacterial cause of meningitis, and with Fraenckel had discovered the pneumococcus Karl Landsteiner： The immunology of syphilis and the Wassermann reaction The cause of poliomyelitis In 1875 Landois had reported the blood transfusion reaction In 1901-1903 Landsteiner pointed out the blood transfusion reaction again In 1909, he classified the bloods into the A, B, AB, and O groups From 1919-1922, 12 papers on new haptens that he had discovered(Hague ) The discovery of the Rh-factor in blood(Rockefeller Institute for Medical Research in New York ) 2 The Nobel Prize in Physiology or Medicine 1930 Karl Landsteiner Austria Rockefeller Institute for Medical Research New York, NY, USA b. 1868 d. 1943 It is characteristic of him that he died pipette in hand. On June 24, 1943, he had a heart attack in his laboratory and died two days later in the hospital of the Institute in which he had done such distinguished work. 3 1939年Gorer在鉴定近交系小鼠血型抗原时发现四组血细胞抗原，后证实第Ⅱ 组抗原与肿瘤及移植物的排斥密切相关，命名为H-2 Peter Gorer (left) and Phillip Levine. 4 两个经典免疫学实验两个经典免疫学实验 1. Assays for Skin Transplantation 2. Assays for T Cell Activation 5 Skin Transplantation 6 7 The Nobel Prize in Physiology or Medicine 1980 for their discoveries concerning genetically determined structures on the cell surface that regulate immunological reactions" Baruj Benacerraf Jean Dausset George D. Snell 1/3 of the prize 1/3 of the prize 1/3 of the prize USA France USA Harvard Medical School Universit?de Paris, Jackson Laboratory Boston, MA, USA Laboratoire Bar Harbor, ME, USA b. 1920 Immuno-Hematologie b. 1903 d. 1996 (in Caracas, Venezuela) Paris, France b. 1916 d. 2009 8 Assays for T cell Activation 9 10 Zinkernagel-Doherty Phenomenon (1974) MHC restriction The term MHC restriction refers to the phenomenon whereby T cells from one individual recognising antigen X fail to recognise cells presenting the same antigen unless the presenting cells express one or more MHC alleles identical to those on the cortical thymic epithelial cells of the individual in which those T cells matured (these alleles will be those expressed by the T cell in a normal animal). This phenomenon derives in part from the requirement to recognise self MHC and in part from the different peptide binding specificity of different MHC alleles. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974 Apr 19;248(450):701-2. 11 The Nobel Prize in Physiology or Medicine 1996 "for their discoveries concerning the specificity of the cell mediated immune defence" Peter C. Doherty Rolf M. Zinkernagel Australia Switzerland St. Jude Children's Research University of Zurich, Institute Hospital of Experimental Immunology Memphis, TN, USA Zurich, Switzerland b. 1940 b. 1944 12 免疫遗传学发展简史 年代 学者 主要贡献 1900 Landsteiner*(1930) 确定人红细胞主要的同种抗原 1900s Carrell(1912 )* 器官移植 1948 Snell和Gorer 发现小鼠H-2系统及其与组织移植的关系 1953 Snell*(1980) H-2系统由K、D两个位点组成 1954 Murray和Thomas(1990)* 肾移植和骨髓移植 1958 Dausset*(1980) 发现第一个人类白细胞抗原（Mac） 1962 Van Rood 鉴定出HLA-B座位 1967 Benacerraf*(1980)和McDevitt 发现并证明Ir基因存在于MHC中 1969 Amos 发现HLA-D座位 1970 Sandberg 鉴定出HLA-C座位 1975 Doherty *(1996) 小鼠H-2b、K抗原对Tc杀伤病毒感染 细胞的限制作用 1978 Rosenthal Ir基因产物Ia抗原参与Mφ-T相互作用 1978 Zinkernagel * (1996) MHC对T细胞发育分化的影响 1987 Tonegawa* Ig的基因结构 *诺贝尔奖获得者，括号内为获奖年代 13 抗原研究 移植研究 功能研究 11 HistocompatibilityHistocompatibility--2,2, HH--22 14 1. Histocompatibility-2, H-2 15 1.1 H-2 class I gene Classical H-2 class I gene: H-2K, H-2D, H-2L Non- Classical H-2 class I gene: H-2Q, H-2T, H-2M 1.2 H-2 class II gene Classical H-2 class II gene: I-A, I-E Non- Classical H-2 class II gene: I-M,I-O Other genes: LMP1, LMP2,TAP1,TAP2 1.3 H-2 class III gene C4A, C4B, Bf, C2, CYP21A,CY21B 16 MHC Molecules Expressed on H-2k/d Antigen Presenting Cells Diagram illustrating various MHC molecules expressed on antigen-presenting cells of a heterozygous H-2k/d mouse. Both the maternal and paternal MHC molecules are expressed. Because the class II molecules are heterodimers, heterologous molecules containing one maternal-derived chain and one paternal-derived chain are produced. The b2-microglobulin component of class I molecules (black) is encoded by a gene on a separate chromosome and may be 17 derived from either parent. d d d d d H-2d: H-2K , H-2IA , H-2IE , H-2S , H-2D H-2b 18 22 HumanHuman leucocyteleucocyte antigenantigen 19 20 2.1 HLA class I gene Classical HLA class I gene: HLA-A, HLA-B, HLA-C Non- Classical HLA class I gene: HLA-E, HLA-F, HLA-G MHC class I chain-related, MIC 2.2 HLA class II gene HLA-DR:DRA,DRB HLA-DQ:DQA,DQB HLA-DP:DPA,DPB HLA-DM:DMA,DMB TAP: TAP1,TAP2 PSMB:PSMB9 (LMP7), PSMB8(LMP2) 2.3 HLA class III gene C4A, C4B, Bf, C2 CYP21A,CY21B HSP70 TNF, LTA, LTB 21 Nature, Vol 401, 28 OCTOBER 1999; 22 23 24 25 Nature Reviews Genetics 5, 889 - 899 (01 Dec 2004) 26 Gene map of the extended major histocompatibility complex (xMHC). Jean Dausset (1916–2009), who received the Nobel Prize of Medicine in 1980 For his discovery of the human major histocompatibility complex (human leukocyte antigen (HLA), died in Palma de Majorca, Spain, on 6 June 2009, at the age of 92. Nature Immunology, August,2009; 10(8): 797 27 3.3. HumanHuman MHCMHC genesgenes areare highlyhighly polymorphicpolymorphic 3.1 polymorphism and allele Nature Reviews Genetics 5, 889 - 899 (01 Dec 2004) 28 MHC class I and class II are polymorphic [variability at a gene locus (variability of alleles) at a frequency higher than predicted by chance] The number of known alleles at various MHC loci increases over time 1996 (122) (111) (239) (207) 1999 (323) (395) Data in 2001 (59) our book (95) is from 2004 2004 (195) (37) (62) (50) (80) (25) (93) (89) (8) (35) (16) (12) (45) (20) (19) (20) (2) 120 23 68 32 503 728 210 414 29 Janeway’s Immunobiology,7/e,2008 3.2 co-dominance and individuality 1 3 8 1 30 31 4 Structure of MHC Class I Molecule Bjorkman and Stern Bjorkman(1987): HLA-A2; Stern(1994): HLA-DR1 32 4 Structure of MHC Class I Molecule 4.1 α chain and β2-microglobulin 4.2 α1,α2 domains and peptide binding cleft 4.3 α3 and β2-MG 33 34 35 Heavy chain: green Peptide: orange β-2M: yellow Proximal CD8ααsubunit: red Distal CD8ααsubunit: blue CD8αα/HLA-A2/peptide 36 Annu. Rev. Immunol. 2006. 24:419–466 MHC: dark blue Peptide : red TCR: green CD8 : yellow CD3: pink, blue, gold orange 37 38 39 40 55 StructureStructure ofof MHCMHC ClassClass IIII MoleculeMolecule 5.1 α chain and βchain 5.2 α1, β1 domains and peptide binding cleft 41 42 43 44 45 46 47 Thierry Boon J Immunol. 2007 Mar 1;178(5):2617-21 48 Science. 1991 Dec 13;254(5038):1643-7. 二十一项值得获诺贝尔生理或医学奖的工作及科学家 1. Mario Capecchi(美国尤他大学U. Utah)，发明基因剔除技术，可能和其他1,2个做基因剔除(Oliver Smithies)或转 基因动物的人合得，也有可能和第一个做出鼠胚胎干细胞的Gail Martin(美国旧金山加州大学UCSF)合得。 (2007 年 生理或医学奖) 2. Bob Horvitz (美国麻省理工学院MIT)，细胞凋亡的遗传机理，可能合得者是：AH Wylie或JFR Kerr其中之一(细 胞凋亡的概念和电子显微镜下形态变化特征)，Susanne Cory或Stanley Korsmeyer之一(Bcl-2在细胞凋亡中的作用)。 得州大学西南医学中心的王晓东也有可能(细胞凋亡的生物化学机理)。（2002年获医学或生理学奖） 4. Elizabeth Blackburn (美国旧金山加州大学UCSF)和Carol Greider (美国霍普金斯大学Johns Hopkins)，端粒子和 端粒酶，Blackburn主要发现在UC Berkeley做，Greider那时是她的学生。（2009年获医学或生理学奖） 5. Roderick MacKinnon (美国洛克菲勒大学Rockefeller)，钾离子通道的结构，可以单独，也可以合得 (不确定合得 者，如果就钾通道而言，旧金山加州大学UCSF的Lily Jan叶公杼和YN Jan詹裕农有可能；如果广义地给离子通道， 美国西雅图华盛顿大学University of Washington的Bertil Hille有可能)。（2003年的化学奖） 8. Roger Y. Tsien 钱永健(美国圣跌哥加州大学UCSD)和 Douglas C. Prasher(美国农业部麻州Otis植物保护中心)，发 明测定活细胞内分子的新方法。Tsien发明钙染料，Prasher发现绿色荧光旦白GFP。（2008年化学奖） 11. Pamela Bjorkman (美国加州理工学院Caltech) 和 Jack Strominger (美国哈佛大学Harvard)发现MHC(主要组 织相容性抗原复合体)结构， Bjorkman是和Don Wiley做研究生时的工作，Wiley如果不去世，应该得。 Emil Unanue (美国圣路易斯华盛顿大学Washington University)，发现抗原呈现细胞。 15. Sydney Brenner 和 Seymour Benzer (美国加州理工学院Caltech)，用遗传学方法研究发育，神经和行为。Brenner 提出用c elegans研究发育和神经，Benzer提出用果蝇做神经和行为。（2002年获医学或生理学奖） 16. Marc Raichle (美国圣路易斯华盛顿大学Washington University),用正电子扫描(PET scan)做活体人影像检测，可 能和发明改进fMRI(“功能性核磁共振”，或称“功能性磁共振影像”)的人合得。 他们的工作是生物医学影像的重要发 展。 (2003年医学或生理学奖) 17. Luc Montagnier(法国)Robert C. Gallo(美国)，发现爱滋病毒。(2008年医学或生理学奖) 49 21. RNA干扰，不一定会在近年发奖，可能等机理进一步搞清，但是发奖时会包括发现RNA干扰现象的人，有三 个重要的候选人，如果不包括机理，就是他们，如果包括机理，那么只能在这三个里面选一俩个加上以后发现RNAi Obituary: Professor Don C. Wiley, 1944-2001 December 21, 2001 Don C. Wiley, one of the most distinguished structural biologists of his generation, has died. He was 57. Wiley, whose teaching and research career spanned three decades at Harvard University, conducted key research on the structure of viruses and of proteins in the human immune system. His work focused on the molecular mechanisms that enable viruses to infect cells, and on how cells respond to external challenges by presenting antigens and mobilizing defensive cells. A senior investigator of the Howard Hughes Medical Institute, Wiley studied the structure of such viruses as the AIDS virus, Ebola, herpes simplex, and influenza. He examined the ways in which viruses bind to cell surfaces, enabling their entry into the cell, and the ways in which viruses evolve to infect different organisms and to escape the immune response of their hosts. By understanding these processes, Wiley sought to find new ways to combat these viruses. Professor Don C. Wiley 50 …… Nature. 2001 Nov 29;414(6863):475. 51 The Death Of Dr. Wiley - 'Murder, They Wrote' By Wayne Madsen CounterPunch.org 6-4-2 The reported "suicide" and then "accidental death" of noted Harvard biophysics scientist and anthrax, Ebola, AIDS, herpes, and influenza expert, Dr. Don C. Wiley, on the Interstate 55 Hernando De Soto Bridge that links Memphis to West Memphis, Arkansas, was probably a well-planned murder, according to local law enforcement officials in Tennessee and Arkansas. After Wiley's friends and family discounted claims of suicide, the Memphis coroner concluded on January 14, 2002 that Wiley had "accidentially" fallen over the side of the bridge after a minor car accident.
Recommended publications
  • Meduni Wien Imagebroschuere

    Meduni Wien Imagebroschuere

    We shape the future Key numbers IN THE TOP 100 worldwide in the medicine category of leading university rankings 8,000 students outpatient treatments annually at Vienna General Hospital 5,750 employees operations annually, including 750 transplants Doing everything to support health Founded in 1365 as the medical faculty of the University of Vienna and made an independent university in 2004, today MedUni Vienna is among Europe’s most highly respected centres of medical training and research. 2 Focused programmes of study MedUni Vienna has an educational offering that ranges from undergraduate degrees to continuing education courses and PhD programmes. MEDICINE DEGREE DENTISTRY DEGREE PROGRAMME PROGRAMME MEDICAL INFORMATICS PHD PROGRAMMES MASTER’S PROGRAMME POSTGRADUATE APPLIED MEDICAL CONTINUING SCIENCE DOCTORAL EDUCATION COURSES PROGRAMME AND CERTIFICATE COURSES Measurable success Since its establishment as an independent university in 2004, research output has grown at MedUni Vienna. This can be seen in the university’s consistent upward progress in significant rankings including the US News Best Global Universities Rankings and the QS World University Rankings. 3 Gerard van Swieten Carl von Rokitansky Josef Skoda Ignaz Philipp Semmelweis Karl Landsteiner Róbert Bárány 4 City of Medicine Medical pioneers: the Vienna School of Medicine Modern medicine was born in the theories of Ignaz Philipp Jewish heritage or dissident Vienna. Gerard van Swieten, Semmelweis in clinical practice thinkers, and were murdered, personal physician to Empress for the first time anywhere in expelled or forced to flee by Maria Theresa, introduced bed- the world. In the 20th century, the National Socialist regime side teaching into medical edu- Karl Landsteiner and Róbert – among them Sigmund Freud, cation in the 18th century.
  • 2004 Albert Lasker Nomination Form

    2004 Albert Lasker Nomination Form

    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
  • Medicine Merit Badge Requirements

    Medicine Merit Badge Requirements

    Columbia-Montour Council MEDICINE NOTES FOR SCOUTS: LIMITED TO 20 SCOUTS 1. Scouts are required to obtain the Medicine merit badge book, study its contents and be prepared to discuss all requirements with the counselor. 2. All items listed in bold type are prerequisites that MUST be completed prior to the event and emailed to your counselor at least 2 weeks before MBC. 3. Scouts are required to download and use the Workbook, and have all requirements filled out before they arrive the day of the event, which may be downloaded at http://www.MeritBadge.org . 4. Counselor: Ralph Baker 570-271-1049, [email protected] Medicine merit badge requirements 1. Discuss with your counselor the influence that EIGHT of the following people or events had on the history of medicine: a. Hippocrates b. William Harvey c. Antoine van Leeuwenhoek d. Edward Jenner e. Florence Nightingale f. Louis Pasteur g. Gregor Mendel h. Joseph Lister i. Robert Koch j. Daniel Hale Williams k. Wilhelm Conrad Roentgen l. Marie and Pierre Curie m. Walter Reed n. Karl Landsteiner o. Alexander Fleming p. Charles Richard Drew q. Helen Taussig r. James Watson and Francis Crick s. Jonas Salk 2. Explain the Hippocratic Oath to your counselor, and compare to the original version to a more modern one. Discuss to whom those subscribing to the original version of the oath owe the greatest allegiance. 3. Discuss the health-care provider-patient relationship with your counselor, and the importance of such a relationship in the delivery of quality care to the patient. Describe the role of confidentiality in this relationship.
  • DMJ.1936.2.1.A02.Young.Pdf (3.644Mb)

    DMJ.1936.2.1.A02.Young.Pdf (3.644Mb)

    DALHOUSIE MEDICAL JOURNAL 5 A Memorable Conference THE HARVARD TERCENTENARY 1636 - 1936 E. GORDON YOUNG, B.A., M.Sc., Ph.D., F.R.S.C. OMEONE has said that the most valuable and rarest thing in the world S is a new idea. It is the verdict or the intellectual world of science, of art and of music that progress centres largely about the thoughts ex­ pressed by the few great minds of the centuries. The work of the scientists of the world has been likened to a great canvas, the subject of which has been chosen by the few and the first bold lines inserted, but the great mass of colour and detail has been supplied by the many faithful apprentices. It was most fitting that the oldest and greatest of American Universities should celebrate its three hundredth birthday in an intellec­ tual feast and that it should invite to its table as leaders of conversation the greatest minds of the world in those subjects which were proposed for discussion. Harvard.!J.as a magnificent record of intellectual tolerance and its hospitality was open to individuals of all nationalities and all re- ligious and political creeds. To Cambridge thus in the early days of September, 1936, there came, by invitation, a group of about two thousand five hundred American and Canadian scholars to participate in a memorable series of symposia led by a special group of sixty-seven eminent scientists and men of letters from fifteen different countries. These included no fewer than eleven men who had the greatest single distinction in the realms of science and of letters, the Nobel Prize.
  • Balcomk41251.Pdf (558.9Kb)

    Balcomk41251.Pdf (558.9Kb)

    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
  • Health and the People Part Four: Modern Medicine

    Health and the People Part Four: Modern Medicine

    TURTON SCHOOL HISTORY DEPARTMENT – KNOWLEDGE ORGANISER – GCSE Modern treatment of disease The impact of war and technology on surgery Modern public health Modern treatment of disease: the development of The impact of war and technology on surgery: plastic surgery; blood transfusions; X‐rays; transplant surgery; modern surgical methods, including lasers, radiation therapy During the Boer War of 1899 to 1902, the government discovered that half the pharmaceutical industry; penicillin, its discovery and keyhole surgery. the volunteers for the army were unfit for service. In the 1900s, therefore, by Fleming, its development; new diseases and the Liberal government passed a string of welfare reforms based on 'the treatments, antibiotic resistance; alternative Surgeons in WW1 had the opportunity to experiment with new techniques. Surgeons developed techniques to repair broken bones, and perform skin grafts – plastic personal principle' – the belief that the government had a responsibility to treatments. surgery. Surgery of the eye, ear, nose and throat all improved rapidly. care for the individual citizen: X‐rays were first discovered 20 years before the war. Hospitals installed X‐ray machines, but it was the First World War which confirmed their importance. X‐rays 1906, local authorities were given the right to provide free school The key discovery in the twentieth century was the immediately improved the success rate of surgeons in removing deeply lodged bullets and shrapnel which would otherwise have caused fatal infections. During WW1 the meals for poor children development of Penicillin; following advances occurred: 1907, the School Medical Service gave free health checks Alexander Fleming 1908, the government introduced pensions for old people Penicillin was discovered by Alexander Fleming when Scientists didn’t know about different blood groups.
  • Timeline of Immunology

    Timeline of Immunology

    TIMELINE OF IMMUNOLOGY 1549 – The earliest account of inoculation of smallpox (variolation) occurs in Wan Quan's (1499–1582) 1718 – Smallpox inoculation in Ottoman Empire realized by West. Lady Mary Wortley Montagu, the wife of the British ambassador to Constantinople, observed the positive effects of variolation on the native population and had the technique performed on her own children. 1796 – First demonstration of smallpox vaccination (Edward Jenner) 1837 – Description of the role of microbes in putrefaction and fermentation (Theodore Schwann) 1838 – Confirmation of the role of yeast in fermentation of sugar to alcohol (Charles Cagniard-Latour) 1840 – Proposal of the germ theory of disease (Jakob Henle) 1850 – Demonstration of the contagious nature of puerperal fever (childbed fever) (Ignaz Semmelweis) 1857–1870 – Confirmation of the role of microbes in fermentation (Louis Pasteur) 1862 – Phagocytosis (Ernst Haeckel) 1867 – Aseptic practice in surgery using carbolic acid (Joseph Lister) 1876 – Demonstration that microbes can cause disease-anthrax (Robert Koch) 1877 – Mast cells (Paul Ehrlich) 1878 – Confirmation and popularization of the germ theory of disease (Louis Pasteur) 1880 – 1881 -Theory that bacterial virulence could be attenuated by culture in vitro and used as vaccines. Proposed that live attenuated microbes produced immunity by depleting host of vital trace nutrients. Used to make chicken cholera and anthrax "vaccines" (Louis Pasteur) 1883 – 1905 – Cellular theory of immunity via phagocytosis by macrophages and microphages (polymorhonuclear leukocytes) (Elie Metchnikoff) 1885 – Introduction of concept of a "therapeutic vaccination". Report of a live "attenuated" vaccine for rabies (Louis Pasteur and Pierre Paul Émile Roux). 1888 – Identification of bacterial toxins (diphtheria bacillus) (Pierre Roux and Alexandre Yersin) 1888 – Bactericidal action of blood (George Nuttall) 1890 – Demonstration of antibody activity against diphtheria and tetanus toxins.
  • ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM

    ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM

    2000–2009 2001 2002 2003 2005 2006 2007 2008 Tim Hunt Robert Horvitz Sir Peter Mansfi eld Barry Marshall Craig Mello Oliver Smithies Luc Montagnier 2000 2000 2001 2002 2004 2005 2007 2008 Arvid Carlsson Eric Kandel Sir Paul Nurse John Sulston Richard Axel Robin Warren Mario Capecchi Harald zur Hauser Nobel Prizes 2000000 2001001 2002002 2003003 200404 2006006 2007007 2008008 Paul Greengard Leland Hartwell Sydney Brenner Paul Lauterbur Linda Buck Andrew Fire Sir Martin Evans Françoise Barré-Sinoussi in Medicine and Physiology 2000 1st Congress of the Latin American Region – in Santiago 2005 ILAE archives moved to Zurich to become publicly available 2000 Zonismide licensed for epilepsy in the US and indexed 2001 Epilepsia changes publishers – to Blackwell 2005 26th International Epilepsy Congress – 2001 Epilepsia introduces on–line submission and reviewing in Paris with 5060 delegates 2001 24th International Epilepsy Congress – in Buenos Aires 2005 Bangladesh, China, Costa Rica, Cyprus, Kazakhstan, Nicaragua, Pakistan, 2001 Launch of phase 2 of the Global Campaign Against Epilepsy Singapore and the United Arab Emirates join the ILAE in Geneva 2005 Epilepsy Atlas published under the auspices of the Global 2001 Albania, Armenia, Arzerbaijan, Estonia, Honduras, Jamaica, Campaign Against Epilepsy Kyrgyzstan, Iraq, Lebanon, Malta, Malaysia, Nepal , Paraguay, Philippines, Qatar, Senegal, Syria, South Korea and Zimbabwe 2006 1st regional vice–president is elected – from the Asian and join the ILAE, making a total of 81 chapters Oceanian Region
  • Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research

    Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research

    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Hollingsworth, Joseph Rogers Working Paper Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research WZB Discussion Paper, No. P 02-003 Provided in Cooperation with: WZB Berlin Social Science Center Suggested Citation: Hollingsworth, Joseph Rogers (2002) : Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research, WZB Discussion Paper, No. P 02-003, Wissenschaftszentrum Berlin für Sozialforschung (WZB), Berlin This Version is available at: http://hdl.handle.net/10419/50229 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence. www.econstor.eu P 02 – 003 RESEARCH ORGANIZATIONS AND MAJOR DISCOVERIES IN TWENTIETH-CENTURY SCIENCE: A CASE STUDY OF EXCELLENCE IN BIOMEDICAL RESEARCH J.
  • Karl Landsteiner (1868–1943): Originator of ABO Blood Classification Siang Yong Tan1, MD, JD, Connor Graham2, MD

    Karl Landsteiner (1868–1943): Originator of ABO Blood Classification Siang Yong Tan1, MD, JD, Connor Graham2, MD

    Singapore Med J 2013; 54(5): 243-244 M edicine in S tamps doi: 10.11622/smedj.2013099 Karl Landsteiner (1868–1943): Originator of ABO blood classification Siang Yong Tan1, MD, JD, Connor Graham2, MD magine practising medicine without access to blood but frequently upon blood cells from other individuals as well”. transfusions. It was Karl Landsteiner, a 1930 Nobel laureate, Although it was well recognised at the time that clumping would who classified human blood into groups based on the occur when blood from different animals was mixed, the idea presence of naturally occurring agglutinating antibodies, that blood from two humans would cause the same reaction was Iand whose findings eventually established safe transfusion novel. Landsteiner experimented with his own blood and that procedures. Prior to his discovery, patients in need of blood of five coworkers, first noting that none of the serum samples received transfusions from animals such as sheep or randomly reacted with each individual’s own red blood cells. However, selected human donors – usually with disastrous consequences. coworker A’s serum reacted with coworker B’s red blood cells. Landsteiner’s discovery literally saved millions of human lives. This was due to the presence of B antigen on coworker B’s red blood cells, which reacted with the naturally occurring antibody in EARLY LIFE AND CAREER Karl Landsteiner was coworker A’s serum that was directed against the B antigen. born on June 14, 1868 in a Jewish quarter referred to as Baden bei Likewise, coworker B’s serum reacted with coworker A’s red Wien, just south of Vienna, Austria.
  • Lasker Interactive Research Nom'18.Indd

    Lasker Interactive Research Nom'18.Indd

    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
  • Previous Recipients of GSA Awards

    Previous Recipients of GSA Awards

    GENETICS | THE 2015 GSA HONORS AND AWARDS Previous Recipients of GSA Awards Thomas Hunt Morgan Medal 1981 Barbara McClintock and 1991 Armin Dale Kaiser 2003 David S. Hogness Marcus M. Rhoades 1992 Edward H. Coe, Jr. 2004 Bruce N. Ames 1982 Sewall Wright 1993 Ray D. Owen 2005 Robert L. Metzenberg 1983 Edward B. Lewis 1994 David D. Perkins 2006 Masatoshi Nei 1984 George W. Beadle and 1995 Matthew Meselson 2007 Oliver Smithies R. Alexander Brink 1996 Franklin W. Stahl 2008 Michael Ashburner 1985 Herschel L. Roman 1997 Oliver Evans Nelson, Jr. 2009 John Roth 1986 Seymour Benzer 1998 Norman H. Horowitz 2010 Alexander Tzagoloff 1987 James F. Crow 1999 Salome G. Waelsch 2011 James Haber 1988 Norman H. Giles 2000 Evelyn M. Witkin 2012 Kathryn V. Anderson 1989 Dan L. Lindsley 2001 Yasuji Oshima 2013 Thomas Douglas Petes 1990 Charles Yanofsky 2002 Ira Herskowitz 2014 Frederick M. Ausubel Genetics Society of America Medal 1981 Beatrice Mintz 1992 Maynard V. Olson 2004 Trudy F. C. Mackay 1982 Gerald R. Fink 1993 Jonathan R. Beckwith 2005 Steven J. Elledge 1983 Charles Yanofsky 1994 Leland H. Hartwell 2006 Victor Ambros 1984 David S. Hogness 1995 Eric Wieschaus 2007 Shirley Tilghman 1985 Philip Leder 1996 Elliot Meyerowitz 2008 Susan Lindquist 1986 Gerald M. Rubin 1997 Christine Guthrie 2009 Marian Carlson 1987 Sydney Brenner 1998 Ronald W. Davis 2010 Barbara Meyer 1988 David Botstein and 1999 Charles H. Langley 2011 John Carlson Ira Herskowitz 2000 Jack W. Szostak 2012 Joanne Chory 1989 Allan C. Spradling 2001 H. Robert Horvitz 2013 Elaine A. Ostrander 1990 Nancy Kleckner 2002 Andrew Z.